| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...620286B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0020286 |
| P932 | PMC publication ID | 3102092 |
| P698 | PubMed publication ID | 21633502 |
| P5875 | ResearchGate publication ID | 51184776 |
| P50 | author | Meinrad Gawaz | Q89518767 |
| Boris Bigalke | Q114402878 | ||
| P2093 | author name string | Konstantinos Stellos | |
| Angela Paul | |||
| Christoph Laske | |||
| Kateryna Sopova | |||
| Elke Stransky | |||
| Brigitte Schreitmüller | |||
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging | Q24629027 | ||
| “Mini-mental state” | Q25938989 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Alzheimer's disease | Q29616743 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project | Q33306599 | ||
| Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques | Q33415488 | ||
| Leptin: a novel therapeutic strategy for Alzheimer's disease | Q34015256 | ||
| Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices | Q34075070 | ||
| Adiponectin and Metabolic Syndrome | Q34269072 | ||
| Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. | Q35945101 | ||
| Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia | Q36568506 | ||
| Leptin increases adult hippocampal neurogenesis in vivo and in vitro | Q36737548 | ||
| Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. | Q36837473 | ||
| Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells | Q36887845 | ||
| Progenitor cells in vascular repair | Q36947991 | ||
| Adiponectin and inflammation: consensus and controversy | Q37025392 | ||
| Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control. | Q37789570 | ||
| Biological action of leptin as an angiogenic factor | Q38333557 | ||
| Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription. | Q38358764 | ||
| Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. | Q40125401 | ||
| Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease | Q40174296 | ||
| Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease | Q40287992 | ||
| Adiponectin and protection against type 2 diabetes mellitus | Q44290932 | ||
| Obesity-related leptin regulates Alzheimer's Abeta | Q45171528 | ||
| Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells | Q46183042 | ||
| Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes | Q46286305 | ||
| Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. | Q46460417 | ||
| Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction | Q47638971 | ||
| Increased circulating progenitor cells in Alzheimer's disease patients with moderate to severe dementia: evidence for vascular repair and tissue regeneration? | Q48328833 | ||
| Acute post-stroke adiponectin in relation to stroke severity, progression and 6 month functional outcome | Q48374436 | ||
| Chronic Leptin Supplementation Ameliorates Pathology and Improves Cognitive Performance in a Transgenic Mouse Model of Alzheimer's Disease | Q48379489 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| More support for vascular basis of Alzheimer's disease | Q48741039 | ||
| Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support? | Q48932840 | ||
| Serum leptin levels are associated with cognitive function in older adults | Q49015940 | ||
| Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. | Q51736251 | ||
| Association of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina. | Q53555338 | ||
| Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain | Q79975223 | ||
| Reduced adiponectin level is associated with severity of coronary artery disease | Q80100128 | ||
| Leptin receptor and functional effects of leptin in human endothelial progenitor cells | Q81839555 | ||
| Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity | Q82468503 | ||
| High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease | Q84971537 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | e20286 | |
| P577 | publication date | 2011-05-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Adipocytokines and CD34 progenitor cells in Alzheimer's disease | |
| P478 | volume | 6 |
| Q36767745 | Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology |
| Q47644425 | Adiponectin and sporadic Alzheimer's disease: Clinical and molecular links. |
| Q36686081 | Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment. |
| Q89964020 | Adipose-Derived Molecules-Untouched Horizons in Alzheimer's Disease Biology |
| Q36026292 | Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectives |
| Q41039610 | Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia. |
| Q47986845 | Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion |
| Q59048785 | Clinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease |
| Q57812922 | Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease |
| Q26750370 | Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease |
| Q93332838 | Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels |
| Q38230391 | Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease |
| Q60046418 | Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer's Disease |
| Q33623924 | Estrogen: a master regulator of bioenergetic systems in the brain and body |
| Q27009988 | Food for thought: the role of appetitive peptides in age-related cognitive decline |
| Q36840174 | Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. |
| Q48218464 | Leptin Regulation of Synaptic Function at Hippocampal TA-CA1 and SC-CA1 Synapses: Implications for Health and Disease. |
| Q33692408 | Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential |
| Q38189680 | Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines |
| Q36587781 | Obesity, leptin, and Alzheimer's disease |
| Q35793436 | Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus |
| Q35569809 | Repositioning leptin as a therapy for Alzheimer's disease |
| Q38930559 | Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors |
| Q48103379 | The Influence of Adipose Tissue on Brain Development, Cognition, and Risk of Neurodegenerative Disorders. |
| Q61448813 | The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer's Disease |
| Q33851630 | The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease |
Search more.